14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 MGNX stock ended at $16.05. This is 1.95% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 4.80% from a day low at $15.62 to a day high of $16.37.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical MacroGenics prices

Date Open High Low Close Volume
Oct 18, 2016 $25.67 $26.34 $25.52 $25.60 174 900
Oct 17, 2016 $25.19 $25.48 $24.10 $25.28 307 400
Oct 14, 2016 $26.51 $26.61 $25.02 $25.12 362 300
Oct 13, 2016 $26.36 $27.19 $25.93 $26.42 286 500
Oct 12, 2016 $29.37 $29.99 $26.46 $26.87 314 000
Oct 11, 2016 $30.40 $31.04 $29.14 $29.51 128 600
Oct 10, 2016 $30.07 $30.99 $29.89 $30.87 106 500
Oct 07, 2016 $30.26 $30.35 $29.36 $29.64 233 700
Oct 06, 2016 $29.90 $30.07 $29.15 $29.75 172 100
Oct 05, 2016 $29.30 $30.19 $29.06 $30.06 123 400
Oct 04, 2016 $29.68 $30.03 $29.00 $29.23 176 800
Oct 03, 2016 $29.64 $29.82 $28.70 $29.59 212 500
Sep 30, 2016 $29.68 $30.23 $29.23 $29.91 165 500
Sep 29, 2016 $32.46 $32.55 $29.37 $29.43 269 100
Sep 28, 2016 $32.32 $32.68 $31.91 $32.37 229 200
Sep 27, 2016 $30.92 $32.18 $30.74 $32.15 309 100
Sep 26, 2016 $32.00 $32.00 $30.90 $31.06 127 000
Sep 23, 2016 $31.37 $32.43 $31.03 $31.31 318 500
Sep 22, 2016 $31.69 $31.99 $31.16 $31.40 153 700
Sep 21, 2016 $31.52 $31.66 $30.26 $31.40 208 100
Sep 20, 2016 $31.18 $31.67 $30.48 $31.28 141 100
Sep 19, 2016 $31.54 $31.85 $30.58 $30.84 143 500
Sep 16, 2016 $30.04 $31.94 $30.04 $31.30 461 200
Sep 15, 2016 $29.01 $30.14 $28.72 $29.97 154 300
Sep 14, 2016 $28.68 $29.89 $28.64 $28.95 220 400
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT